IMPAVIDO

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 71863-135
  • Package NDC 71863-135-28
  • Application number NDA204684
  • SPL ID 5f670cb6-e6ee-ecc6-e063-6394a90a71fc
  • SPL set ID 57c515c8-f4af-b876-e063-6394a90af0cc
  • UNII 53EY29W7EC
  • RxCUI 1494071
  • RxCUI 1495070

What the source publishes

Labeler
Eton Pharmaceuticals, Inc.
Active ingredients
Miltefosine
Form
CAPSULE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:71863-135_5f670cb6-e6ee-ecc6-e063-6394a90a71fc
{
  "name": "IMPAVIDO",
  "splId": "5f670cb6-e6ee-ecc6-e063-6394a90a71fc",
  "labels": [
    {
      "setId": "57c515c8-f4af-b876-e063-6394a90af0cc",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=57c515c8-f4af-b876-e063-6394a90af0cc",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=57c515c8-f4af-b876-e063-6394a90af0cc"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Eton Pharmaceuticals, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "2 BLISTER PACK in 1 CARTON (71863-135-28)  / 14 CAPSULE in 1 BLISTER PACK",
      "package_ndc": "71863-135-28",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260926"
    }
  ],
  "productId": "71863-135_5f670cb6-e6ee-ecc6-e063-6394a90a71fc",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE",
  "productNdc": "71863-135",
  "deaSchedule": null,
  "genericName": "Miltefosine",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "MILTEFOSINE",
      "strength": "50 mg/1"
    }
  ],
  "applicationNumber": "NDA204684",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20260926",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000190851"
    ],
    "unii": [
      "53EY29W7EC"
    ],
    "rxcui": [
      "1494071",
      "1495070"
    ],
    "spl_set_id": [
      "57c515c8-f4af-b876-e063-6394a90af0cc"
    ],
    "pharm_class_epc": [
      "Antileishmanial [EPC]"
    ],
    "manufacturer_name": [
      "Eton Pharmaceuticals, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:71863-135_5f670cb6-e6ee-ecc6-e063-6394a90a71fc"